Zortix matched this thesis to Healthcare ETFs as one way for retail investors to get exposure. Not a recommendation.
Wuxi biofoundry twins a global oligopoly bet
The guest argued that WuXi AppTec and WuXi Biologics are positioned to be part of a global oligopoly in pharmaceutical contract manufacturing ('biofoundry').
Sign in to read the full idea
The argument, what validates it, the risks discussed and hearing it from the source are for signed-in members. Free accounts read 3 ideas in full a day. No card required.